Oral contraceptives, fibrinogen and cardiovascular risk
- 31 March 1992
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 93 (1-2) , 1-5
- https://doi.org/10.1016/0021-9150(92)90194-l
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.BMJ, 1991
- Fibrinogen as a major risk factor in cardiovascular diseaseTrends in Pharmacological Sciences, 1990
- Plasma fibrinogen — an independent cardiovascular risk factorJournal of Internal Medicine, 1990
- Plasma fibrinogen and coronary risk factors: The Scottish heart health studyJournal of Clinical Epidemiology, 1990
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Effects of Oral Contraceptives on Blood Coagulation. A ReviewObstetrical & Gynecological Survey, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project.BMJ, 1984
- Altered haemorheology in oral-contraceptive users.BMJ, 1980